As per reports, Joaquin Duato, Johnson & Johnson (JNJ) CEO has been elected to lead as the Chairman succeeding Alex Gorsky, effective January next year. Gorsky to step down from his role as executive chairman.
J&J veteran Duato replaced Gorsky as CEO earlier this year after leading a variety of roles for more than 30 years with the company. He also held a crucial role in J&J’s COVID-19 response and helped streamline its pharmaceutical business strategy.
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare-focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also provides select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.